Osteocalcin Improves Nonalcoholic Fatty Liver Disease in Mice through Activation of Nrf2 and Inhibition of JNK

被引：0
|
作者：
Du, Jing
Zhang, Mingliang
Bao, Yuqian
机构：
来源：
DIABETES | 2016年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1799-P
引用
收藏
页码：A464 / A465
页数：2
相关论文
共 50 条
  • [1] Osteocalcin improves nonalcoholic fatty liver disease in mice through activation of Nrf2 and inhibition of JNK
    Bao, Yuqian
    Du, Jing
    Zhang, Mingliang
    Lu, Junxi
    Zhang, Xueli
    Xiong, Qin
    Xu, Yiting
    Jia, Weiping
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S139 - S139
  • [2] Osteocalcin improves nonalcoholic fatty liver disease in mice through activation of Nrf2 and inhibition of JNK
    Du, Jing
    Zhang, Mingliang
    Lu, Junxi
    Zhang, Xueli
    Xiong, Qin
    Xu, Yiting
    Bao, Yuqian
    Jia, Weiping
    ENDOCRINE, 2016, 53 (03) : 701 - 709
  • [3] Osteocalcin improves nonalcoholic fatty liver disease in mice through activation of Nrf2 and inhibition of JNK
    Jing Du
    Mingliang Zhang
    Junxi Lu
    Xueli Zhang
    Qin Xiong
    Yiting Xu
    Yuqian Bao
    Weiping Jia
    Endocrine, 2016, 53 : 701 - 709
  • [4] Erythritol Improves Nonalcoholic Fatty Liver Disease by Activating Nrf2 Antioxidant Capacity
    Jin, Meiyu
    Wei, Yunfei
    Yu, Hao
    Ma, Xin
    Yan, Siru
    Zhao, Lilei
    Ding, Lu
    Cheng, Jiaqi
    Feng, Haihua
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2021, 69 (44) : 13080 - 13092
  • [5] Liraglutide improves nonalcoholic fatty liver disease by regulation of sestrin2-mediated activation of AMPK/Nrf2/HO-1 pathway in obese mice
    Han, X.
    Han, F.
    Pan, R.
    Hou, N.
    Liu, Y.
    Sun, X.
    DIABETOLOGIA, 2019, 62 : S530 - S530
  • [6] Osteocalcin Alleviates Nonalcoholic Fatty Liver Disease in Mice through GPRC6A
    Zhang, Mingliang
    Nie, Xiaomin
    Yuan, Yeqing
    Wang, Yansu
    Ma, Xiaojing
    Yin, Jun
    Bao, Yuqian
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2021, 2021
  • [7] Tangeretin improves hepatic steatosis and oxidative stress through the Nrf2 pathway in high fat diet-induced nonalcoholic fatty liver disease mice
    Ke, Zunli
    Tan, Si
    Li, Haiyang
    Jiang, Shanshan
    Li, Yuping
    Chen, Rui
    Li, Mingxia
    FOOD & FUNCTION, 2022, 13 (05) : 2782 - 2790
  • [8] Chemical Activators of the Nrf2 Signaling Pathway in Nonalcoholic Fatty Liver Disease
    He, Yinghua
    Jiang, Jianping
    He, Beihui
    Shi, Zheng
    NATURAL PRODUCT COMMUNICATIONS, 2021, 16 (01)
  • [9] Scutellarin ameliorates nonalcoholic fatty liver disease through the PPARγ/PGC-1α-Nrf2 pathway
    Zhang, Xiaoxue
    Ji, Renpeng
    Sun, Huijun
    Peng, Jinyong
    Ma, Xiaodong
    Wang, Changyuan
    Fu, Yufeng
    Bao, Liuchi
    Jin, Yue
    FREE RADICAL RESEARCH, 2018, 52 (02) : 198 - 211
  • [10] Mechanism of Action and Related Natural Regulators of Nrf2 in Nonalcoholic Fatty Liver Disease
    Yu, Wenfei
    Zhang, Fengxia
    Meng, Decheng
    Zhang, Xin
    Feng, Yanan
    Yin, Guoliang
    Liang, Pengpeng
    Chen, Suwen
    Liu, Hongshuai
    CURRENT DRUG DELIVERY, 2024, 21 (10) : 1300 - 1319
12345